Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
210M
-
Number of holders
-
109
-
Total 13F shares, excl. options
-
68.7M
-
Shares change
-
+1.69M
-
Total reported value, excl. options
-
$382M
-
Value change
-
+$5.09M
-
Put/Call ratio
-
0.32
-
Number of buys
-
57
-
Number of sells
-
-43
-
Price
-
$5.56
Significant Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) as of Q2 2017
144 filings reported holding BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share as of Q2 2017.
BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) has 109 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 68.7M shares
of 210M outstanding shares and own 32.76% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (11.7M shares), BlackRock Inc. (6.26M shares), VANGUARD GROUP INC (6.01M shares), RA CAPITAL MANAGEMENT, LLC (5.16M shares), STATE STREET CORP (3.91M shares), DEERFIELD MANAGEMENT CO (3.5M shares), MILLENNIUM MANAGEMENT LLC (3.41M shares), RTW INVESTMENTS, LP (3.33M shares), FMR LLC (3.12M shares), and VHCP Management II, LLC (2.48M shares).
This table shows the top 109 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.